Cell Signaling Technology
Cell Signaling Technology’s Summer Internship Program offers paid, full-time, hands-on laboratory training for undergraduate students across product development, production, and research. Interns work Monday–Friday under the mentorship of CST scientists, gaining practical laboratory experience and professional development, with returning interns often given priority for future positions. The program runs May 26, 2026 to August 14, 2026 and has a defined application window in December–January.
Headquarters
Danvers, Massachusetts, United States
Company Size
501-1000 employees
Founded
1999
Cell Signaling Technology (CST) is a private, family‑owned company founded by scientists that develops and supplies high‑quality antibodies, reagents, proteomics tools, kits, and consumables for biomedical research and diagnostics. CST emphasizes rigorous antibody validation and is frequently ranked highly for specificity and sensitivity, offering products and workflows designed to accelerate biological discovery and enable personalized medicine. The company pairs in‑house research and quality control with technical support to help labs reproducibly measure signaling pathways and biochemical targets.
Sustainability Is in Cell Signaling Technology’s DNA
Feb 1, 2024
Cell Signaling Technology: The life science company that life scientists built
Apr 16, 2022
Leveragen Partners with Cell Signaling Technology to Advance Reagent Antibody Innovation with Proprietary Nanobody Technology
Mar 25, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Cell Signaling Technology.
Cell Signaling Technology, Inc.
Nov 3, 2022